Alerts
View all our safety alerts, medicine shortage alerts and product recalls.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Shortages (6)
- Alert/Advisory (42)
- Medicine safety (28)
- Safety (24)
- Regulatory compliance (17)
- Import and export (12)
- Medical devices safety (10)
- Prescription medicines (10)
- Complementary medicines (8)
- Therapeutic goods regulation (8)
- Australian Register of Therapeutic Goods (ARTG) (7)
- Over the counter (OTC) medicines (7)
- Listed medicines (6)
- Non-prescription medicines (3)
- Advertising (2)
- Assessed listed medicines (1)
- Compliance and enforcement hub (1)
- Labelling and packaging (1)
- Weight loss products (1)
Search
6 result(s) found, displaying 1 to 6
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Medicine shortage alertsThe supply of Ozempic (semaglutide) will continue to be limited until 31 December 2025
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Medicine shortage alertsPharmacists may dispense alternative brands or strengths without a new prescription.
-
Medicine shortage alertsPharmacists can now substitute one Orencia 125 mg product for the other